Wegovy ~16.9% average body weight loss Boosts metabolic & cardiovascular health Proven, long-established safety profile Weekly injection, easy to use Key Facts: Wegovy and Kidney Stone Risk Current evidence does not show a direct causal link between Wegovy and kidney stones
Distinguishing true response from reduced potency is presented as the whole point
By targeting receptors in the brain and gastrointestinal tract, Zepbound not only helps to curb hunger but also enhances feelings of fullness after meals
10.1038/s41392-020-00456-5 103 WongL
GLP-1RA can induce glucose-dependent stimulation of insulin secretion, reduce glucagon release, reduce hepatic glucose output, delay gastric emptying and increase satiety, resulting in moderate reductions in glycated hemoglobin (HbA1c), body weight and systolic blood pressure, the risk of hypoglycemia is lower
Module 6 covers special populations, sex-specific protocols, CVD prevention, and the future of GLP-1 research
